Genes can tell which kidney transplant recipients don’t need lifelong drugsMay 25th, 2010 - 4:56 pm ICT by ANI
Washington, May 27 (ANI): A pattern of genes could soon identify kidney transplant recipients that do not need immunosuppressive drugs for the rest of their lives, a new study has claimed.
Generally, such recipients need these drugs for a lifetime, but a handful of people, out of the thousands who have undergone transplantation, can stop taking these drugs without losing their kidneys.
In a study on these rare individuals, researchers have identified a pattern of genes turned on in their white blood cells, which may one day be used to help identify other transplant recipients who could reduce or completely taper their immunosuppressive therapy without ill effect.
Dr. Kenneth Newell led the study, performed by the Immune Tolerance Network (ITN), an international research consortium with headquarters at University of California, San Francisco.
The authors emphasize that their study looked at “tolerant” patients.
These are patients who had stopped taking their prescribed immunosuppressive medications for at least a year, yet did not reject their kidneys. They are not encouraging others to follow the same course of action.
“The signature that we discovered in these individuals may be useful for identifying kidney transplant recipients who are already tolerant. Whether or not this same signature will identify those kidney transplant recipients still taking immunosuppressive medications who are predisposed to developing tolerance in the future remains unknown,” said Newell.
“Carefully supervised studies will be necessary to answer this question as well as to determine whether attempting to completely withdraw all immunosuppressive drugs will prove advantageous in the long term,” he added.
“In the vast majority of patients, stopping or reducing immunosuppression medications without doctor supervision will have serious health consequences, including loss of the transplanted kidney. We certainly don’t encourage anyone to try this on their own,” cautioned Newell.
The ITN study examined 25 kidney transplant recipients who had ceased taking their immunosuppressive drugs and yet had retained normal kidney function for more than one year.
The researchers compared this group with two other groups-recipients who were still taking their medication and had healthy kidneys, as well as healthy, non-transplanted controls.
The ITN team analysed the genes turned on in samples of blood cells from each of the three groups and observed that the transplant recipients who were not taking medication had a distinct pattern of genes turned on in B cells, a type of white blood cell.
Further study showed that zeroing in on three B cell genes could distinguish patients who had stopped taking their medications yet maintained good graft function.
White blood cells include both T and B cells. Most studies of immune tolerance have focused on the role of a subset of T cells, called regulatory T cells (Tregs).
However, more recent work in animal models indicates that some kinds of B cells may also help regulate the immune system and promote tolerance of a transplanted organ.
“We expected to find a difference between the tolerant and immunosuppression groups in the genes associated with Tregs. However, we were surprised that our data showed that B cell genes may play an important role in maintaining and possibly inducing tolerance to transplanted organs,” said Newell.
The results of the study were reported in the Journal of Clinical Investigation. (ANI)a
- Experimental drug better for kidney transplant - Mar 04, 2010
- Mums' stem cells could be key to treating genetic disease before birth - Jan 19, 2011
- Cell population responsible for body's immune response identified - Mar 07, 2011
- Study reveals new warning signs that may predict kidney transplant failure - Sep 03, 2010
- 'Statins prevent cancer in heart transplant patients' - May 20, 2012
- Now, a blood test to detect organ transplant rejection - Sep 25, 2010
- HPV infection 'increases skin cancer risk' - Jul 09, 2010
- Iraqi woman gets new life with bone marrow transplant in India - Sep 23, 2010
- 'Mini' transplant may safely reverse severe sickle cell disease in adults - Dec 10, 2009
- Kidney cells could help do away with transplants - Jul 28, 2011
- Delhi homemaker gets new heart - May 31, 2011
- Mechanism behind organ transplant rejection uncovered - Nov 19, 2010
- New study shows evidence of stem cells' pivotal role in cancer - Dec 22, 2010
- Algorithm to separate blood sample into different cell types and detect changes - Mar 08, 2010
- Killer white blood cells could make organ rejection history - Aug 22, 2010
Tags: california san francisco, dr kenneth, genes, handful, health consequences, ill effect, immune tolerance network, immunosuppressive drugs, immunosuppressive medications, immunosuppressive therapy, kidney transplant recipients, kidneys, newell, rare individuals, research consortium, serious health, transplantation, university of california, university of california san francisco, white blood cells